WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2005037278) TBENAZPRIL AND AMLODIPINE FOR REDUCING CARDIOVASCULAR MORBIDITY
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2005/037278 International Application No.: PCT/EP2004/011824
Publication Date: 28.04.2005 International Filing Date: 19.10.2004
IPC:
A61K 31/44 (2006.01) ,A61K 31/55 (2006.01) ,A61P 9/00 (2006.01) ,A61P 9/04 (2006.01) ,A61P 9/10 (2006.01) ,A61P 9/12 (2006.01)
Applicants: JAMERSON, Ken[US/US]; US (UsOnly)
MAC NAB, Malcolm[US/US]; US (UsOnly)
PITT, Bertram[US/US]; US (UsOnly)
NOVARTIS AG[CH/CH]; Lichtstrasse 35 CH-4056 Basel, CH (AE, AG, AL, AM, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NA, NE, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, SN, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW)
NOVARTIS PHARMA GMBH[AT/AT]; Brunner Strasse 59 A-1230 Vienna, AT (AT)
Inventors: JAMERSON, Ken; US
MAC NAB, Malcolm; US
PITT, Bertram; US
Agent: GRUBB, Philip; Novartis AG Corporate Intellectual Property CH-4002 Basel, CH
Priority Data:
60/512,63420.10.2003US
Title (EN) TBENAZPRIL AND AMLODIPINE FOR REDUCING CARDIOVASCULAR MORBIDITY
(FR) UTILISATION DE COMPOSES ORGANIQUES
Abstract:
(EN) The present invention is related to a method for reducing cardiovascular morbidity and/or mortality comprising administering a combination comprising an ACE inhibitor and a CCB, specifically benazapril and amlodipine besylate.
(FR) L'invention concerne un procédé pour réduire la morbidité et/ou la mortalité cardio-vasculaire, consistant à administrer une combinaison comprenant un inhibiteur de l'ACE et un inhibiteur calcique, en particulier du benazepril et du besylate d'amlodipine.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)